In 2023, Norway, Iceland, and Slovakia demonstrated the highest per capita spending on musculo-skeletal medicines, showcasing growth driven by Norway's conservative growth and Iceland's and Slovakia's rapid increases. Canada, the Czech Republic, and Australia also contributed positively, while Belgium, Finland, Sweden, and New Zealand showed declining trends. Particularly notable are the substantial reductions seen in Mexico and New Zealand. Over the past five years, these countries have displayed varying compound annual growth rates, with Slovakia and Iceland leading the charge.
Future trends to monitor include:
- Increasing investments in healthcare across Scandinavia.
- Potential shifts in market dynamics driven by aging populations in Europe.
- Adoption of technological advancements influencing consumption patterns globally.
- Economic factors affecting affordability and access in Mexico and New Zealand.
Top countries in Musculo-Skeletal System Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Norway | 27.2 | 2023 | 0% | +0.68% | View data |
| 2 | 2 Iceland | 26.9 | 2023 | +0.37% | +6.21% | View data |
| 3 | 3 Slovakia | 24.8 | 2023 | +2.9% | +6.27% | View data |
| 4 | 4 Canada | 23 | 2023 | -0.86% | +2.43% | View data |
| 5 | 5 Czech Republic | 22.6 | 2023 | +15.9% | +0.18% | View data |
| 6 | 6 Belgium | 21.8 | 2023 | -0.91% | -2.31% | View data |
| 7 | 7 Finland | 21.5 | 2023 | +0.47% | -0.28% | View data |
| 8 | 8 Sweden | 19.6 | 2023 | +4.26% | -0.2% | View data |
| 9 | 9 Australia | 18.2 | 2023 | +2.82% | +3.94% | View data |
| 10 | 10 Slovenia | 17.3 | 2023 | +18.49% | +11.36% | View data |
